CRVO
CervoMed Inc.
2.50$
-0.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -94.7% | +668.0% | +49.5% | -30.4% | +33.4% | +14.2% | +36.5% | -89.0% | +139.9% | +332.0% | -45.7% | |
| – | -91.5% | -21.5% | +502.8% | -7.8% | +64.3% | +28.2% | +101.4% | -89.0% | +139.7% | +332.3% | -47.6% | |
| – | -90.9% | -22.2% | +472.9% | -10.2% | +77.4% | +30.6% | +101.5% | -89.0% | +90.4% | +15.5% | -8.5% | |
| – | -90.9% | -22.2% | +472.9% | -10.2% | +77.4% | +30.6% | +101.5% | -89.0% | +90.4% | +399.5% | -46.4% | |
| – | – | – | – | – | – | – | – | – | – | +146.3% | -81.1% | |
| – | – | – | +0.0% | – | – | – | – | – | – | – | – | |
| – | +0.0% | +33.9% | +0.0% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | |
| – | -49.7% | +258.0% | -40.8% | -47.3% | +60.0% | -29.7% | +0.4% | +349.4% | -80.3% | +49.4% | +33.4% | |
| – | -37.1% | +201.7% | -39.4% | -70.1% | +114.1% | +41.5% | +20.2% | +349.4% | -80.3% | +49.4% | +20.0% | |
| – | – | +342.4% | -70.7% | – | – | +1.8% | +3,522.1% | +202.0% | – | – | – | |
| – | +1.8% | +296.6% | -69.6% | -61.2% | +529.4% | -56.4% | +73.6% | -89.7% | +580.8% | +128.2% | -3.8% | |
| – | -100.1% | – | +131.1% | -26.5% | +29.0% | +23.2% | +40.7% | -125.8% | – | +431.4% | -53.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -81.7% | +3,805.4% | +24.7% | +281.3% | +106.8% | +702.7% | +81.4% | -60.2% | +413.6% | +203.4% | +12.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.